Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
What's New in Metastatic Breast Cancer Research
Nancy Lin, MD, of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, discusses the differences between breast cancer subtypes and looks at recent drug approvals and research directions for the future.
Nancy Lin, MD, of the Susan F. Smith Center for Women’s Cancers at the Dana Farber Cancer Institute, discusses the differences between breast cancer subtypes and looks at recent drug approvals and research directions for the future.
Related Videos
Related Content
